Katie Nixon, CIO at Northern Trust Wealth Management, joined Yahoo Finance’s The Final Round to discuss her outlook for the market and investor sentiment.
from Yahoo Finance https://ift.tt/2V0oaOk
-
What you’re reading in the newspaper today is not what the market is valuing: CIO
-
These fantastic healthcare ASX shares could make you wealthy
The world’s population is getting older and will continue to do so over the coming decades.
According to data from the United Nation’s World Population Prospects: the 2019 Revision, by 2050, one in six people will be over the age of 65 globally.
In addition to this, the number of people aged 80 years or over is projected to triple from 143 million in 2019 to 426 million in 2050.
Given these huge shifts in demographics, demand for healthcare services is expected to increase materially over the next three decades.
In light of this, I think that investing in the healthcare sector is a smart move.
But which shares should you buy? Sticking with quality seems like the best move in my eyes, which means these three healthcare stars could be the ones to buy today:
Cochlear Limited (ASX: COH)
The first healthcare share to look at buying is Cochlear. I think the hearing solutions company has a very positive long term outlook thanks to its exposure to the aforementioned ageing populations tailwind. This is because as people age, their hearing will generally fade and require some form of assistance. I expect this to lead to increasing demand for hearing solutions products over the next couple of decades.
CSL Limited (ASX: CSL)
My favourite healthcare share is this biotherapeutics giant. I believe that both its CSL Behring and Seqirus businesses are well-placed to deliver strong sales and earnings growth over the next decade. This is thanks to their in-demand therapies and vaccines and their lucrative research and development pipelines. Within CSL’s current pipeline are therapies that have the potential to generate billions of dollars in sales over the next decade.
Ramsay Health Care Limited (ASX: RHC)
A final healthcare share to consider buying is Ramsay Health Care. It is a leading private healthcare company with a total of 480 facilities across 11 countries. Given its global footprint, I believe Ramsay’s network is well-placed to benefit greatly from the expected increase in demand for healthcare services in the future. This could make it worth looking beyond the short term headwinds it is facing and focusing on its positive long term outlook.
And here are more exciting shares which could be destined for big things…
One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.
Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- How to turn $20,000 into $250,000 in 10 years with ASX shares
- Why I’m desperate to add CSL and 2 other ASX shares to my portfolio in 2020
- Is the Cochlear share price in the buy zone now that it’s down 23%?
- I would buy and hold Kogan and these ASX shares until 2030
- 3 undervalued ASX growth companies to add to your portfolio
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post These fantastic healthcare ASX shares could make you wealthy appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/3dhYDq1
-
Are these small cap ASX tech shares the next Afterpay or Appen?
The likes of Afterpay Ltd (ASX: APT) and Appen Ltd (ASX: APX) weren’t always multi-billion dollar tech companies.
At one stage they were small cap tech shares flying under the radar, just like the ones listed below.
Whether these three shares will follow in their footsteps, only time will tell, but I think they are well worth keeping a very close eye on. Here’s why I like them:
ELMO Software Ltd (ASX: ELO)
The first small cap ASX tech share to watch is this cloud-based human resources and payroll software company. ELMO provides users with a unified platform that streamlines processes such as recruitment, on-boarding, learning, and payroll. It has a sizeable market opportunity in the ANZ market and the potential to expand globally in the future. This is thanks to its platform being jurisdiction agnostic.
Volpara Health Technologies Ltd (ASX: VHT)
Another small cap ASX tech share to watch is this healthcare technology company. Volpara’s software uses artificial intelligence imaging algorithms to assist with the early detection of breast cancer. Demand for its software has been growing strongly, leading to the company recently delivering a 172% increase in annual recurring revenue (ARR) to NZ$18 million in FY 2020. This is still only scratching at the surface of an estimated US$750 million ARR opportunity in breast cancer screening.
Whispir (ASX: WSP)
A final small cap ASX tech share to watch is this software-as-a-service communications workflow platform company. It provides an industry-leading software platform that allows users to deliver actionable two-way interactions at scale using automated multi-channel communication workflows. During the first half of FY 2020, its annualised recurring revenue increased 22% to $36.7 million. Pleasingly, the second half looks set to be even stronger thanks to the work from home initiative.
And here are more exciting shares which could be stars of the future…
We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.
And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!
*Extreme Opportunities returns as of June 5th 2020
More reading
- Top brokers name 3 ASX 200 shares to buy next week
- Where to invest $10,000 into ASX shares next week
- Which shares to buy if the ASX tumbles
- How to become a millionaire in 25 years with $20 a day
- These were the best performers on the ASX 200 last week
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of VOLPARA FPO NZ and Whispir Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Elmo Software. The Motley Fool Australia owns shares of and has recommended Elmo Software. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. The Motley Fool Australia has recommended VOLPARA FPO NZ and Whispir Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Are these small cap ASX tech shares the next Afterpay or Appen? appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2BuX0YI
The Latest
-
Woolworths vs JB Hi-Fi: Which ASX shares to buy now?
-
9,627 shares of Wesfarmers pay an income equal to the Age Pension
-
CBA vs Coles shares: Which is the better buy at age 50?
-
If I invest $15,000 in NAB shares, how much passive income will I receive in 2027?